Brief: PDS Biotechnology Says On Nov. 21 Matthew Hill Submitted His Resignation, Effective December 1, 2023, As CFO
Nov 28 (Reuters) - PDS Biotechnology Corp PDSB.O :
* PDS BIOTECHNOLOGY CORP - ON NOVEMBER 21 MATTHEW HILL
SUBMITTED
HIS RESIGNATION, EFFECTIVE DECEMBER 1, 2023, AS CFO
* PDS BIOTECHNOLOGY CORP - LARS BOESGAARD WILL ASSUME ROLE
OF
COMPANY'S CHIEF FINANCIAL OFFICER, EFFECTIVE AS OF DECEMBER 4,
2023
* PDS BIOTECHNOLOGY CORP - AS OF DECEMBER 4 BOESGAARD WILL
ALSO
SERVE AS COMPANY'S PRINCIPAL FINANCIAL OFFICER AND PRINCIPAL
ACCOUNTING OFFICER
Further company coverage: PDSB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing